Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide
Stopped Suspended 15th of Nov 2023 due to conditions affecting recruitment process.
Conditions
Interventions
- DRUG: rifampicin
- DRUG: pyrazinamide
- DRUG: HRZE
- DRUG: HR
Sponsor
University Hospital, Linkoeping
Collaborators